Australia · Delayed Price · Currency is AUD Universal Biosensors Company Description
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally.
The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO₂, malic acid, glucose, fructose, total acid, and titratable acidity.
It also provides non-diagnostic laboratory services and coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans.
Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.
| Country | United States |
| Founded | 2001 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 76 |
| CEO | Peter Mullin |
Contact Details
Address: 1 Corporate Avenue Rowville, Delaware 3178 Australia | |
| Phone | 61 3 9213 9000 |
| Website | universalbiosensors.com |
Stock Details
| Ticker Symbol | UBIO |
| Exchange | Australian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | AUD |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Peter Mullin | Chief Executive Officer |
| Peter Mullin | Chief Financial Officer |